BioStock: Q1 report signals expansion period for Fluicell

Fluicell is off to a promising start in 2020. This much was clear in the Q1 report released by the Swedish single-cell technology company two weeks ago. The sales numbers are indicative of a strong first quarter for Fluicell with further expansion on the horizon, mainly thanks to the broad range of innovative products that the company already has on the market and its newly established CRO activities.

Read the full article at biostock.se:

https://www.biostock.se/en/q1-report-signals-expansion-period-for-fluicell/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se